How has Chemed's deferred tax assets, net of valuation allowance changed year-over-year?

Chemed's deferred tax assets, net of valuation allowance increased by 3.1% year-over-year, from $98.79M to $101.82M.

What is the long-term trend for Chemed's deferred tax assets, net of valuation allowance?

Over 5 years (2020 to 2025), Chemed's deferred tax assets, net of valuation allowance has grown at a 2.0% compound annual growth rate (CAGR), from $92.04M to $101.82M.

Chemed CHE Deferred Tax Assets, Net of Valuation Allowance

Deferred Tax Assets, Net of Valuation Allowance at other companies

Corebridge FinancialCRBG

$7.82B-13.6%

Rockwell AutomationROK

$766M+11.7%

TPG Inc.TPG

$1.1B+74.1%

MSCIMSCI

$189.76M+3.9%

Bank of AmericaBAC

$21.87B-6.2%

PNC Financial ServicesPNC

$3.5B-25.2%

Other financials

Income statement

See full

Revenue$657.5M+1.6%

Gross profit$215.8M-0.3%

Operating income$84.6M-10.7%

Net income$66.3M-7.6%

EPS (diluted)$4.84-0.4%

Balance sheet

See full

Cash & equivalents$16.9M-90.3%

Total debt$236.9M+63.3%

Total equity$848.0M-28.2%

Total assets$1.5B-11.0%

Cash flow

See full

Operating cash flow$88.2M+169%

CapEx$17.1M+28.9%

Free cash flow$71.1M+265%

Valuation

See full

Market cap$5.79B-42.3%

Enterprise value$6.01B-39.6%

P/E22.3×-10.2×

P/S2.3×-1.8×

Profitability

See full

Gross margin32.4%-2.4pp

Operating margin12.9%-2.7pp

Net margin10.2%-2.2pp

FCF margin14.8%+2.2pp

Returns & leverage

See full

Return on equity25.6%-0.5pp

Debt / equity0.3×+0.2×

Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsNet.

The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's deferred tax assets, net of valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Chemed's deferred tax assets, net of valuation allowance?: Chemed (CHE) reported deferred tax assets, net of valuation allowance of $101.82M in Q4 2025.
How has Chemed's deferred tax assets, net of valuation allowance changed year-over-year?: Chemed's deferred tax assets, net of valuation allowance increased by 3.1% year-over-year, from $98.79M to $101.82M.
What is the long-term trend for Chemed's deferred tax assets, net of valuation allowance?: Over 5 years (2020 to 2025), Chemed's deferred tax assets, net of valuation allowance has grown at a 2.0% compound annual growth rate (CAGR), from $92.04M to $101.82M.